Revenue was $4.3 billion, up 2% year-over-year, driven by our diversified end market mix and includes $1 billion of pass-through substrate sales.
We have revised our fiscal year 2021 value-added revenue guidance to a range of $13.55 billion to $13.65 billion, which compares to our prior range of $13.8 billion $14.1 billion.
We have reduced our 2021 adjusted EBITDA range from $1.25 billion to $1.28 billion from a range of $1.36 billion to $1.44 billion.
